The broad clinical adoption of artificial intelligence (AI) in medicine is rapidly increasing worldwide. The Munich-based LMU University Hospital has been working on AI solutions for clinical practice and research applications to continuously improve clinical workflows and patient care. For their Department of Radiology, the LMU University Hospital has now entered a close strategic partnership […]
Following years of close collaboration, Philips will strengthen its partnership with the ESR at the European Congress of Radiology 2023, where it will take over an entire Congress floor. Level 2, to be named Philips@TheBlue Level at the 2023 meeting, will host the company alongside many of its most innovative products, services and partnerships. With this commitment, Philips will hold […]
GE HealthCare announced today that its previously announced spin-off from GE is complete and GE HealthCare will begin trading as an independent company on the Nasdaq exchange under the ticker symbol “GEHC” effective at the market opening today. GE HealthCare will be the first company in the state of Wisconsin to remotely ring Nasdaq’s opening […]
A major new study has shown that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs [1]. Mammograms acquired through population-based breast cancer screening programs produce a significant workload for radiologists. Read more here: AI shows potential in Breast Cancer screening DIEurope June 2022
Breast biopsies provide an in-depth analysis of lesions and calcifications after they have been discovered during a woman’s wellness visit. They play a vital role in ensuring the correct diagnosis—meaning minutes matter when it comes to breast biopsies. Read more here: Hologic Brevera Prof Moschetta Biopsies June 2022
The number of papers describing the application of Artificial Intelligence ( AI) derived algorithms in radiology in general is growing exponentially. In the field of breast imaging in particular, the Transpara AI software developed by the Dutch company ScreenPoint Medical Read more here: Mark Koeniguer Screenpoint Medical Interview June 2022
The finding several years ago that small amounts of gadolinium (Gd) could be deposited in the brains of patients who had received several doses of certain gadolinium-based contrast agents (GBCAs), (albeit without any apparent clinical consequences) prompted the European regulatory authorities to withdraw some GBCAs Read more here :New Gadolinium Contrast Agent Guerbet Bourrinet […]
The number of papers published on the use of Artificial Intelligence (AI) in radiology is growing exponentially, with the field of breast imaging being highly active in the implementation of AI approaches, which are no longer restricted to exploratory R&D and evaluation studies but are now being increasingly implemented in clinical routine Read more […]
Over the last few years, there has been a continuing, ever-increasing interest and debate over the role that Artificial Intelligence (AI) – based technologies can, and should, play in radiology. Now the debate is over, AI in radiology is here to stay Read more here :AI in radiology Prof O’Regan Bayer June 2022
An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a recent study in Radiology: Artificial Intelligence [1]. Breast density reflects the amount of fibroglandular tissue in the breast commonly seen on mammograms. Read More here: New AI TEchnology Breast Density DIEurope Spring 2022
The Swiss company b-rayZ — a spin-off from the University Hospital Zurich, Switzerland and a pioneer in the application of artificial intelligence (AI) technologies to the field of breast imaging — and the German company AB-CT – Advanced Breast-CT, based in Erlangen, Germany Read More here: Breast Imaging AI solutions CT Rossi Kalender AB-CT […]
By Dr. KGA Gilhuijs Breast density is a risk factor for developing breast cancer [1-4]. In fact, women in the highest breast-density category (i.e., BI-RADS class D) are at a risk of developing cancer Read More her: AI in Automated Triaging of Breast Screening MRI examinations Gilhuijs DIE Spring 2022.
By Dr. Matthew J Kuhn, Dr. Julia W Patriarche & Dr. Miles A Kirchin Gadolinium-based contrast agents (GBCAs) work by shortening the T1, T2, and T2* relaxation time constants of adjacent water protons in tissues. The greater the T1 shortening the greater the signal enhancement obtained on T1-weighted images. Read More here: MRI macrocyclic […]
By Dr. Melissa Hill Optimal image quality is fundamental for effective breast screening. The development of powerful AI-based systems for breast quality assurance has the potential not just to minimize the number of repeat imaging and patient recalls but also to greatly improve quality in general. Read More here: Volpara Health DIEurope March 2022